- Supported exchanges /
- NSE /
- ORTINLAB.NSE
Ortin Laboratories Limited (ORTINLAB NSE) stock market data APIs
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
Ortin Laboratories Limited Financial Data Overview
| 19.63 | |
| 19.63 | |
| - | |
| 19.63 | |
| 19.63 | |
| 16.2-26.35 | |
| 166 M | |
| 8 131 K | |
| 7 492 K | |
| 1.36 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Ortin Laboratories Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 7 492 K
- EBITDA -67 733 248
- Earnings Per Share -10.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Ortin Laboratories Limited Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Ortin Laboratories Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
